Stocks to Watch: ASCO -continued-INCY, ONXX, SUPG
This is a continuation of pre-ASCO coverage, reviewing companies that will have significant clinical presentations on cancer products in their pipeline. Incyte Corporation (INCY $17.82) up 1.94%. is focused on small molecule drugs for hematological and oncology applications and for chronic...
New: Guide to Biotech Investing and ETF’s
Our recent article on biotech investing and ETF's in general are posted on Investor Uprising. Note to get the article on the right side of the page you need to register at no charge for Investor Uprising. Investor Uprising - IU Education - Guide to Biotech...
Stocks to Watch: ASCO Presentations for ARIA,DNDN,ECYT and EXEL
Here is a brief review of stocks to watch with potential ASCO impact although it is likely that prices already reflect the scientific news: Ariad Pharmaceuticals Inc. (ARIA $8.43) up 0.36% will present Phase III data on ponatinab, its investigational pan-BCR-ABL and ridaforolimus an mTOR...
Medical Science News Ramping Up for ASCO
A bull market in life science stocks has revved up news for the upcoming ASCO Meeting on June 3 in Chicago. We will provide limited coverage of stocks to watch and scientific articles of interest. However it is clear that many PR shops and newsletters are busy preparing investors with lists of...
Personalized Healthcare Gets a Boost from Nestle/Prometheus Deal
The Life Science market consolidation trend continued today as Nestle SA acquires privately held Prometheus Laboratories, Inc. of San Diego,CA for about $567M according to a Bloomberg story although the price was not disclosed. Other stories put the price closer to $1B.Prometheus was...